Jaguar8
reacted to
$Mobile-health Network Solutions(MNDR.US$ Sure was a great week for the DCB. Well again Y’all know how much i like me some bottoms! Hehehe. Well it seems that today this hit that big ole bottom again! ATL/52wk low. This is actually the second time. It previously hit 1.07 and bounced off of it. Seem like it may be MS? Time will tell. Anyway my point is that i do believe i will move this to the top of my WATCH for a possible DCB. NFA just thinking outloud
1
Jaguar8
commented on
$CEL-SCI(CVM.US$ If it can break 1.70? Will be looking for 1.83, 1.96 and 2.19 NFA. just thinking outloud
2
15
$Camber Energy(CEI.US$
Camber Energy Announces Proposed Settlement of Stockholder Derivative Action
HOUSTON, TX / ACCESSWIRE / July 26, 2024 / Camber Energy, Inc. (NYSE:CEI), a growth-oriented energy company ("Camber" or the "Company") announces today, that on July 2, 2024, the United States District Court for the Southern District of Texas, issued an order providing for preliminary approval of a proposed settlement of the claims asserted nominally on behalf of Camber against the individual...
Camber Energy Announces Proposed Settlement of Stockholder Derivative Action
HOUSTON, TX / ACCESSWIRE / July 26, 2024 / Camber Energy, Inc. (NYSE:CEI), a growth-oriented energy company ("Camber" or the "Company") announces today, that on July 2, 2024, the United States District Court for the Southern District of Texas, issued an order providing for preliminary approval of a proposed settlement of the claims asserted nominally on behalf of Camber against the individual...
$Cognition Therapeutics(CGTX.US$
Cognition Therapeutics to Host Investor Webcast to Discuss Results from Proof-of-Concept Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease at 8:30am ET on Monday July 29, 2024
Cognition Therapeutics (NASDAQ: CGTX) will host an investor webcast on July 29, 2024, to discuss results from the Phase 2 SHINE study of CT1812 in mild-to-moderate Alzheimer's disease.
The study enrolled 153 adults, randomized to receive 100mg or 300mg of CT1812 or...
Cognition Therapeutics to Host Investor Webcast to Discuss Results from Proof-of-Concept Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease at 8:30am ET on Monday July 29, 2024
Cognition Therapeutics (NASDAQ: CGTX) will host an investor webcast on July 29, 2024, to discuss results from the Phase 2 SHINE study of CT1812 in mild-to-moderate Alzheimer's disease.
The study enrolled 153 adults, randomized to receive 100mg or 300mg of CT1812 or...
$Cheetah Net Supply Chain Service(CTNT.US$
Cheetah Net Supply Chain Service Inc. Announces Closing of $1.49 Million Follow-on Public Offering
Cheetah Net Supply Chain Service Inc. Announces Closing of $1.49 Million Follow-on Public Offering
Jaguar8
commented on
$Zapata Computing(ZPTA.US$ seems like something may be happening with these increase stakes ownership…
4
Jaguar8
commented on
$ProMIS Neurosciences(PMN.US$
ProMIS Neurosciences Reports Positive Top-Line Data from its Phase 1a Alzheimer's Trial
▪️ProMIS Neurosciences (Nasdaq: PMN) has reported positive top-line data from the first four cohorts of its Phase 1a clinical trial of PMN310 in healthy volunteers for Alzheimer's disease. The results showed:
▪️A favorable safety profile and tolerability across four ascending dose levels
▪️Dose-dependent levels of PMN310 antibody in cerebrospinal fluid (CSF)
Potential...
ProMIS Neurosciences Reports Positive Top-Line Data from its Phase 1a Alzheimer's Trial
▪️ProMIS Neurosciences (Nasdaq: PMN) has reported positive top-line data from the first four cohorts of its Phase 1a clinical trial of PMN310 in healthy volunteers for Alzheimer's disease. The results showed:
▪️A favorable safety profile and tolerability across four ascending dose levels
▪️Dose-dependent levels of PMN310 antibody in cerebrospinal fluid (CSF)
Potential...
2
6
$Diana Shipping(DSX.US$
Diana Shipping Inc. Announces Signing and Drawdown of a US$167.3 Million Term Loan Facility With Nordea Bank to Refinance Two Existing Term Loan Facilities With Nordea
Diana Shipping Inc. Announces Signing and Drawdown of a US$167.3 Million Term Loan Facility With Nordea Bank to Refinance Two Existing Term Loan Facilities With Nordea